About Celldex Therapeutics
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
|
|
|
201-500 employees
View all Celldex Therapeutics employees
|
|
Biotechnology Research
|
|
$10M–$50M
|
|
(781) 433-3200
|
|
53 Frontage Road, Suite 220, Hampton, NJ 08827, US
|
|
Oncology, Inflammation, Inflammatory Diseases, Immuno-Oncology, Inflammatory Diseases, Oncology, Urticaria, Immunotherapies, Therapeutic Antibodies, Immune System Modulators, Immunothérapies, Immuno-Oncology, Therapeutic Antibodies, Inflammation, Urticária
|
Celldex Therapeutics Alternatives
Frequently Asked Questions about Celldex Therapeutics
Anthony Marucci is the CEO of Celldex Therapeutics. To contact Anthony Marucci email at [email protected].
The decision makers in Celldex Therapeutics are Bradley Bloom, Diane Young, Freddy Jimenez, etc. Click to Find Celldex Therapeutics decision makers emails.
Celldex Therapeutics headquarters is located at 53 Frontage Road, Suite 220, Hampton, NJ 08827, US.
Celldex Therapeutics generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Celldex Therapeutics by calling (781) 433-3200.
Celldex Therapeutics Staff Directory
Search Celldex Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
